Marshall Wace, LLP Rezolute, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Rezolute, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 843,144 shares of RZLT stock, worth $3.96 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
843,144
Previous 1,128,553
25.29%
Holding current value
$3.96 Million
Previous $5.47 Million
26.53%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding RZLT
# of Institutions
76Shares Held
44.6MCall Options Held
201KPut Options Held
2.8K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$53 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$13.4 Million0.69% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$13.1 Million2.6% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$11.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$10.9 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $182M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...